<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04663269</url>
  </required_header>
  <id_info>
    <org_study_id>87943342</org_study_id>
    <nct_id>NCT04663269</nct_id>
  </id_info>
  <brief_title>Regional Erector Spinae Analgesic Block vs Standard of Care Undergoing Percutaneous Nephrolithotomy</brief_title>
  <official_title>Randomized, Prospective Trial of Regional Erector Spinae Analgesic Block Versus Standard of Care in Patients Undergoing Percutaneous Nephrolithotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if adding a spinal block (medicine that will numb&#xD;
      parts of the body to block pain) along with standard pain control at the incision site will&#xD;
      decrease the need for narcotics for pain management and decrease the percentage of patients&#xD;
      requiring hospital admission for pain control during postoperative , in-hospital, care after&#xD;
      a percutaneous nephrolithotomy (PCNL) (surgery to remove kidney stones), commonly called&#xD;
      PERC.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Drop out from surgeons from 3 to 1. It will take too long to feasibly accrue with only one&#xD;
    provider.&#xD;
  </why_stopped>
  <start_date type="Actual">February 24, 2020</start_date>
  <completion_date type="Actual">September 24, 2020</completion_date>
  <primary_completion_date type="Actual">September 11, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Anesthesia will know the randomization assignment. The surgeon and the patient will be blinded to randomization.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Overnight Admission Rate</measure>
    <time_frame>24 hours</time_frame>
    <description>Percentage of patients in Groups 1 and 2 who require overnight admission to the hospital for pain control postoperatively (i.e. patients unable to be discharged to home from the postoperative anesthesia care unit PACU).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Narcotic for Analgesia post-operatively</measure>
    <time_frame>14 days post-op</time_frame>
    <description>Comparison of the percentage of patients in Groups 1 and 2 who require any narcotic for analgesia during the postoperative course following PCNL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with Emergency Department return or re-admission</measure>
    <time_frame>14 days</time_frame>
    <description>Proportion of patient successfully discharged from PACU without return to Emergency Department or requiring re-admission within 14 days post discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Narcotic administrations post-operatively</measure>
    <time_frame>14 days</time_frame>
    <description>Of patients requiring narcotics during the hospitalization, how many administrations of narcotics did these patients receive</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Morphine Equivalents post-operatively</measure>
    <time_frame>14 days</time_frame>
    <description>Of patients requiring narcotics during the hospitalization, how many administrations of narcotics did these patients receive in daily morphine equivalents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of complications peri and post-operatively</measure>
    <time_frame>24 hours</time_frame>
    <description>Any complications (according to Clavien-Dindo classification11) during the surgery and postoperative hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>24 hours</time_frame>
    <description>Maximum patient reported pain score within the first 24 hours post operatively using 0-10 numeric pain intensity scale (NPIS) where 0 is no pain, 5 is moderate pain and 10 is the worst possible pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Adjunct Analgesics Post-operatively</measure>
    <time_frame>14 days</time_frame>
    <description>Nonsteroidal Anti-inflammatories&#xD;
Y/N&#xD;
If Yes, name &amp; dose&#xD;
If Yes, total # of times administered&#xD;
If Yes total # of times administered/(LOS in hours/24)&#xD;
Gabbapentinoids&#xD;
Y/N&#xD;
If Yes, name &amp; dose&#xD;
If Yes, total # of times administered&#xD;
If Yes total # of times administered/(LOS in hours/24)&#xD;
Acetaminophen&#xD;
Y/N&#xD;
If Yes, name &amp; dose&#xD;
If Yes, total # of times administered&#xD;
If Yes total # of times administered/(LOS in hours/24)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Kidney Stone</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard Care Protocol - peritubal block standard local analgesic administration in the form of a peritubal block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ANES Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to the erector spinae block (Group 2) will have the block placed in the preoperative area by the anesthesia team. 0-4 mg midazolam and/or 0-100 mcg of fentanyl may be provided prior to and in order to place the block itself. The local anesthetic will diffuse to involve the dorsal and ventral rami of the spinal nerves, achieving a sensory block of the affected area. The erector spinae block analgesic will be administered by the anesthesia team. The analgesic provided in the erector spinae block is 20mL of 0.5% Bupivicaine with 4mg of PF Dexamethasone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>4mg PF Dexamethasone</intervention_name>
    <description>analgesic provided in the erector spinae block is 20mL of 0.5% Bupivicaine with 4mg of PF Dexamethasone</description>
    <arm_group_label>ANES Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control Test</intervention_name>
    <description>Peritubal block - standard local analgesic administration</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Standard of Care</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Age ≥ 18 years Undergoing unilateral or bilateral PCNL for treatment of kidney stones&#xD;
        Estimated glomerular filtration rate &gt; 30 mL/min. PCNL is planned as an outpatient&#xD;
        procedure with no overnight hospital stay&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Inability to provide informed consent Pregnancy Patients having any additional simultaneous&#xD;
        procedures other than a contralateral PCNL,(including contralateral treatment of kidney&#xD;
        stones with a non-PCNL operation such as ureteroscopy) Patients with a documented&#xD;
        neurologic injury that reduces pain sensation to the back Patients with an existing pain&#xD;
        disorder Patients with an existing narcotics agreement due to current or prior narcotic&#xD;
        abuse Patients with a documented allergy to a narcotic or NSAID analgesic BMI &gt; 35 Patients&#xD;
        who require more than 1 site of percutaneous access into the kidney to adequately complete&#xD;
        the PCNL (this is a judgment made preoperatively at the initial clinic patient encounter)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tim Large, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Methodist University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Jonnavithula N, Pisapati MV, Durga P, Krishnamurthy V, Chilumu R, Reddy B. Efficacy of peritubal local anesthetic infiltration in alleviating postoperative pain in percutaneous nephrolithotomy. J Endourol. 2009 May;23(5):857-60. doi: 10.1089/end.2008.0634.</citation>
    <PMID>19397429</PMID>
  </reference>
  <reference>
    <citation>Parikh GP, Shah VR, Modi MP, Chauhan NC. The analgesic efficacy of peritubal infiltration of 0.25% bupivacaine in percutaneous nephrolithotomy - A prospective randomized study. J Anaesthesiol Clin Pharmacol. 2011 Oct;27(4):481-4. doi: 10.4103/0970-9185.86591.</citation>
    <PMID>22096280</PMID>
  </reference>
  <reference>
    <citation>Ozkan D, Akkaya T, Karakoyunlu N, Arık E, Ergil J, Koc Z, Gumus H, Ersoy H. Effect of ultrasound-guided intercostal nerve block on postoperative pain after percutaneous nephrolithotomy : prospective randomized controlled study. Anaesthesist. 2013 Dec;62(12):988-94. doi: 10.1007/s00101-013-2253-z. Epub 2013 Nov 1.</citation>
    <PMID>24173546</PMID>
  </reference>
  <reference>
    <citation>Honey RJ, Ghiculete D, Ray AA, Pace KT. A randomized, double-blinded, placebo-controlled trial of intercostal nerve block after percutaneous nephrolithotomy. J Endourol. 2013 Apr;27(4):415-9. doi: 10.1089/end.2012.0418.</citation>
    <PMID>23445266</PMID>
  </reference>
  <reference>
    <citation>Yang H, Yu X, Hu J, Peng E, Li C, Cui L, Zhao C, Wang S, Wei C, Mei W, Wang S, Ye Z. Usage of Multilevel Paravertebral Block as the Main Anesthesia for Mini-Invasive PCNL: Retrospective Review of 45 Cases with Large Stones. Urol Int. 2017;99(3):326-330. doi: 10.1159/000480094. Epub 2017 Aug 30.</citation>
    <PMID>28850954</PMID>
  </reference>
  <reference>
    <citation>Jonnavithula N, Chirra RR, Pasupuleti SL, Devraj R, Sriramoju V, Pisapati MV. A comparison of the efficacy of intercostal nerve block and peritubal infiltration of ropivacaine for post-operative analgesia following percutaneous nephrolithotomy: A prospective randomised double-blind study. Indian J Anaesth. 2017 Aug;61(8):655-660. doi: 10.4103/ija.IJA_88_17.</citation>
    <PMID>28890561</PMID>
  </reference>
  <reference>
    <citation>Hatipoglu Z, Gulec E, Turktan M, Izol V, Arıdogan A, Gunes Y, Ozcengiz D. Comparative study of ultrasound-guided paravertebral block versus intravenous tramadol for postoperative pain control in percutaneous nephrolithotomy. BMC Anesthesiol. 2018 Feb 17;18(1):24. doi: 10.1186/s12871-018-0479-7.</citation>
    <PMID>29454333</PMID>
  </reference>
  <reference>
    <citation>Malekpour M, Hashmi A, Dove J, Torres D, Wild J. Analgesic Choice in Management of Rib Fractures: Paravertebral Block or Epidural Analgesia? Anesth Analg. 2017 Jun;124(6):1906-1911. doi: 10.1213/ANE.0000000000002113.</citation>
    <PMID>28525509</PMID>
  </reference>
  <reference>
    <citation>Yeying G, Liyong Y, Yuebo C, Yu Z, Guangao Y, Weihu M, Liujun Z. Thoracic paravertebral block versus intravenous patient-controlled analgesia for pain treatment in patients with multiple rib fractures. J Int Med Res. 2017 Dec;45(6):2085-2091. doi: 10.1177/0300060517710068. Epub 2017 Jun 21.</citation>
    <PMID>28635359</PMID>
  </reference>
  <reference>
    <citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13.</citation>
    <PMID>15273542</PMID>
  </reference>
  <reference>
    <citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.</citation>
    <PMID>18929686</PMID>
  </reference>
  <reference>
    <citation>Miller NL, Matlaga BR, Lingeman JE. Techniques for fluoroscopic percutaneous renal access. J Urol. 2007 Jul;178(1):15-23. Epub 2007 May 11. Review.</citation>
    <PMID>17574053</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 20, 2020</study_first_submitted>
  <study_first_submitted_qc>December 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2020</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>Tim Large</investigator_full_name>
    <investigator_title>Assistant Professor of Urology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

